Role of Axillary Staging in Women Diagnosed With Ductal Carcinoma In Situ With Microinvasion

Abstract

DCISM comprises 0.6% of breast cancer diagnoses at our institution. There is a low likelihood of nodal spread; however, a lack of identifiable clinicopathologic features associated with a positive SLNB limits selective SLNB use.